ADT	Androgen Deprivation Therapy
AWD	Alive with disease
BCR	Biochemical Recurrence
BED	Biologically Effective Dose
bRFS	Biochemical Relapse-free Survival
cRFS	Clinical Relapse-free Survival
CR	Clinical Recurrence
CT	Computed Tomography
CTV	clinical target volume
G	Grade
GI	Gastrointestinal
GU	Genitourinary
HR	Hazard Ratio
IQR	Interquartile range
mp	Multi-parametric
MRI	Magnetic Resonance Imaging
NCCN	National Comprehensive Cancer Network
NED	Not evidence of disease
OS	Overall Survival
PCa	Prostate Cancer
PET	Positron Emission Tomography
PFS	Progression-free Survival
PSMA	Prostate-specific Membrane Antigen
RP	radical prostatectomy
SBRT	Stereotactic Body Radiation Therapy